Redwood Park Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Buy
2,097
+13
+0.6% +$1.5K 0.17% 39
2025
Q4
$219K Buy
2,084
+16
+0.8% +$1.5K 0.15% 44
2025
Q3
$174K Buy
2,068
+18
+0.9% +$1.48K 0.11% 44
2025
Q2
$162K Sell
2,050
-534
-21% -$42.4K 0.11% 45
2025
Q1
$232K Sell
2,584
-2
-0.1% -$187 0.19% 38
2024
Q4
$257K Buy
+2,586
New +$267K 0.18% 34

Other funds holding MRK

Redwood Park Advisors's MRK Position: Q1 2026 in Review

Redwood Park Advisors increased its Merck (MRK) stake by 0.62% in Q1 2026, buying an estimated $1.5K and bringing the position to 2,097 shares worth $252K. The position accounts for 0.17% of the portfolio, ranked #39.

Redwood Park Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $257K in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Redwood Park Advisors held 2,097 shares of Merck worth $252K as of Q1 2026.
  • Redwood Park Advisors bought 13 Merck shares in Q1 2026, an estimated $1.5K.
  • Merck made up 0.17% of Redwood Park Advisors's portfolio in Q1 2026, its #39 holding.
  • Redwood Park Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Redwood Park Advisors's Merck position peaked at $257K in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Redwood Park Advisors's 13F filing for Q1 2026, filed 4 May 2026.